Moderate to Severe Rheumatoid Arthritis
6 clinical trials · Condition
◉ Watch Moderate to Severe Rheumatoid Arthritis
| Record | Firm | Date |
|---|---|---|
| MSB11022 in Moderate to Severe Rheumatoid Arthritis (NCT03052322) | Fresenius Kabi SwissBioSim GmbH | 2017-01-31 |
| Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab (NCT01927757) | Amgen | 2013-05-06 |
| Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA (NCT01117480) | AbbVie (prior sponsor, Abbott) | 2005-07-01 |
Track Moderate to Severe Rheumatoid Arthritis automatically
Every clearance here is in the API, with alerts when new ones post.